Back
Primerica Vs. Viking Therapeutics Industry Stock Comparison
Sell
40
PRI
Primerica
Last Price:
227.73
Seasonality Move:
3.36%
Sell
40
VKTX
Viking Therapeutics
Last Price:
52.02
Seasonality Move:
-3.44%
Sell
40
Primerica (PRI)
is a Sell
Is Primerica a Buy, Sell or Hold?
- The current Primerica [PRI] share price is $227.77. The Score for PRI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PRI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $52.02. The Score for VKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $52.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
PRI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 54.87 | Buy |
| Chaikin Money Flow: | 124880 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (222.81 - 227.85) | Buy |
| Bollinger Bands (100): | (220.55 - 246.49) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.67 | Sell |
| Relative Strength Index (14 RSI): | 31.29 | Sell |
| Chaikin Money Flow: | -100679 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.48 - 68.5) | Sell |
| Bollinger Bands (100): | (41.94 - 80.24) | Sell |
PRI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 224.34 | Buy |
| 20-day SMA: | 225.33 | Buy |
| 50-day SMA: | 223.04 | Buy |
| 200-day SMA: | 219.55 | Buy |
| 8-day EMA: | 224.27 | Buy |
| 20-day EMA: | 224.47 | Buy |
| 50-day EMA: | 226.18 | Buy |
| 200-day EMA: | 218.79 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.59 | Sell |
| 20-day SMA: | 58.92 | Sell |
| 50-day SMA: | 66.79 | Sell |
| 200-day SMA: | 37.75 | Buy |
| 8-day EMA: | 53.96 | Sell |
| 20-day EMA: | 58.63 | Sell |
| 50-day EMA: | 62.68 | Sell |
| 200-day EMA: | 45.29 | Buy |
Primerica Earnings Growth & PRI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.62 per share, an increase next quarter of $0.27 per share, an increase this year of $1.65 per share, and an increase next year of $2.04 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.
Primerica Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||